 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Apeiron Biologics Spins Off New Mass Spec Research and Dx Firm Attoquant Diagnostics
December 07, 2012
Apeiron Biologics Spins Off New Mass Spec Research and Dx Firm Attoquant Diagnostics
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Immundiagnostik Deal Offers Thermo Fisher Chance to Highlight Immunoaffinity Mass Spec Workflows
October 26, 2012 / ProteoMonitor - Agilent Inks Collaboration with Gachon University for Glycoprotein Biomarker Research
July 20, 2012 / ProteoMonitor - New Instruments, Applications Powering Rise of MALDI-MS as Clinical Proteomics Platform
January 20, 2012 / ProteoMonitor - Quest Launches Pair of Rheumatoid Arthritis Biomarker Tests Based on Protein Licensed from Augurex
April 12, 2013 / ProteoMonitor - Matrix-Bio Licenses Metabolomic Biomarkers to Quest for Breast Cancer Test Development
April 11, 2013 / GenomeWeb Daily News